Vivid Explorer/Vivid Advanced/Vivid Focus
GE Medical Systems Ultrasound and Primary Care Diagnostics · Decision date Sep 2, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 2, 2026 for K261313, covering the GE Medical Systems Ultrasound and Primary Care Diagnostics diagnostic ultrasound systems marketed as Vivid Explorer, Vivid Advanced and Vivid Focus. The submission is a traditional 510(k) under 21 CFR 892.1550 (Ultrasonic Pulsed Doppler Imaging System), Class II, with primary product code IYN and subsequent codes IYO, ITX and QIH; the review panel and medical specialty are Radiology. SESE means clearance to market, not premarket approval. The public record lists the primary predicate as K223832 (Vivid S70N/S60N) and reference devices including K251169, K243628, K242005, K243620 and several Vivid E95 clearances.
The summary describes three configurations sharing a common operator interface and console electronics, with differences in cleared scope: Vivid Explorer is stated to have indications identical to the Vivid S70N predicate, Vivid Advanced is similar but without 3D/4D imaging modes, and Vivid Focus is similar but not intended for EP lab use, without intracardiac or intraluminal applications or 3D/4D modes, and is stated to match the Vivid T9 (K243628) indications. The database page lists receipt on 04/21/2026 while the summary letter is dated July 31, 2026, and the page indicates a Predetermined Change Control Plan was authorized. The full intended-use text and the scope of that authorized plan are not reproduced in the available excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261313
- Regulatory pathway
- 510(k) premarket notification
- Product code
- IYN
- Decision code
- SESE
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.
- Product code
- IYN
- FDA device class
- 2
FDA decision timeline
K261313 received
Application receipt date recorded by FDA.
K261313 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| Samsung Medison Co., Ltd. | 510(k) clearance | Oct 8, 2026 | FDA | |
| GE Medical Systems Ultrasound and Primary care Diagnostics, LLC | 510(k) clearance | Oct 2, 2026 | FDA | |
| Philips Ultrasound, LLC | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GE Medical Systems Ultrasound and Primary Care Diagnostics
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Waukesha, WI
Sources and methodology
- Original FDA record: K261313
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


